Form 4: Somu Subramaniam Reports Distribution of Ventyx Biosciences Shares

Somu Subramaniam, a director and 10% owner of Ventyx Biosciences, reports the distribution of shares from NSV Investments to its limited partners, resulting in a change in beneficial ownership.

Summary

• On June 24, 2024, Somu Subramaniam, a director and 10% owner of Ventyx Biosciences, reported a transaction involving the distribution of common stock.
• NSV Investments I, L.P. distributed 125,651 shares, NSV Investments II, L.P. distributed 232,180 shares, and NSV Investments III, L.P. distributed 283,496 shares to their respective limited partners.
• Following the transaction, Subramaniam's indirectly beneficially owned securities amount to 7,102,969 shares.
• These shares are held through various entities including NSV Investments I, L.P., NSV Partners III, L.P., New Science Ventures, LLC, and NSV Partners II, LLC.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, ensuring fair market practices.

Stakeholder Impact

• The distribution of shares may have a minor impact on shareholders due to the change in ownership structure.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates